Royal Bank of Canada’s T2 Biosystems, Inc TTOO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-271
Closed 7413
2024
Q4
$0 Sell
271
-3,730
-93% -$3.12K ﹤0.01% 7443
2024
Q3
$8K Buy
4,001
+1,146
+40% +$4.35K ﹤0.01% 6416
2024
Q2
$15K Buy
2,855
+1,471
+106% +$6.14K ﹤0.01% 6198
2024
Q1
$4K Buy
1,384
+82
+6% +$383 ﹤0.01% 6554
2023
Q4
$8K Buy
+1,302
New +$9.95K ﹤0.01% 6570
2021
Q4
Hold
0
7988
2021
Q3
Hold
0
7952
2021
Q1
Hold
0
7771
2020
Q4
Hold
0
7358
2020
Q3
Hold
0
7030
2020
Q2
Hold
0
6993
2020
Q1
Sell
-12
Closed -$49.9K 7127
2019
Q4
$70K Hold
12
﹤0.01% 5274
2019
Q3
$150K Hold
12
﹤0.01% 4611
2019
Q2
$101K Sell
12
-1
-8% -$11.7K ﹤0.01% 4875
2019
Q1
$176K Buy
13
+4
+44% +$68.1K ﹤0.01% 4432
2018
Q4
$133K Buy
9
+8
+800% +$188K ﹤0.01% 4584
2018
Q3
$53K Hold
1
﹤0.01% 5205
2018
Q2
$40K Hold
1
﹤0.01% 5253
2018
Q1
$35K Buy
+1
New +$26.9K ﹤0.01% 5227
2017
Q4
Hold
0
6990
2017
Q3
Hold
0
7060
2017
Q2
Hold
0
-$3K 6833
2017
Q1
Hold
0
6371
2016
Q4
Hold
0
6309
2016
Q1
Hold
0
6722
2015
Q4
Hold
0
6868
2015
Q3
Hold
0
6319
2015
Q2
Hold
0
6138
2015
Q1
Hold
0
6467
2014
Q4
Hold
0
6331

Royal Bank of Canada's TTOO Position: Q1 2025 in Review

Royal Bank of Canada sold out of T2 Biosystems, Inc (TTOO) in Q1 2025, closing a stake of 271 shares.

Royal Bank of Canada first reported a position in TTOO in Q1 2018 and held it in 13 quarters. The position peaked at $176K in Q1 2019. 2 funds tracked by Wall St. Rank hold TTOO as of Q1 2025.

  • Royal Bank of Canada reported no remaining T2 Biosystems, Inc position as of Q1 2025 after selling out during the quarter.
  • Royal Bank of Canada sold 271 T2 Biosystems, Inc shares in Q1 2025.
  • Royal Bank of Canada first reported a position in T2 Biosystems, Inc in Q1 2018 and held it in 13 quarters.
  • Royal Bank of Canada's T2 Biosystems, Inc position peaked at $176K in Q1 2019.
  • 2 funds tracked by Wall St. Rank held T2 Biosystems, Inc as of Q1 2025.

Based on Royal Bank of Canada's 13F filing for Q1 2025, filed 15 May 2025.